alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          FEB-29-1996
<PERIOD-START>                             MAR-01-1995
<PERIOD-END>                               NOV-30-1995
<CASH>                                           6,016
<SECURITIES>                                         0
<RECEIVABLES>                                    5,780
<ALLOWANCES>                                         0
<INVENTORY>                                    225,215
<CURRENT-ASSETS>                                     0
<PP&E>                                           9,778
<DEPRECIATION>                                   3,128
<TOTAL-ASSETS>                                 258,620
<CURRENT-LIABILITIES>                           33,378
<BONDS>                                        160,615
<COMMON>                                         1,500
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                     211,888
<TOTAL-LIABILITY-AND-EQUITY>                   258,620
<SALES>                                         92,182
<TOTAL-REVENUES>                                95,114
<CGS>                                           77,306
<TOTAL-COSTS>                                   77,306
<OTHER-EXPENSES>                                17,729
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                     79
<INCOME-TAX>                                        28
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                        51
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
```

[Federal Register Volume 75, Number 250 (Thursday, December 30, 2010)]
[Notices]
[Pages 82411-82412]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-32980]

=======================================================================
-----------------------------------------------------------------------

LEGAL SERVICES CORPORATION

Sunshine Act Meeting

DATE AND TIME: The Legal Services Corporation Board of Directors will 
meet telephonically on January 3, 2011 at 2:30 p.m., Eastern Time.

LOCATION: The Legal Services Corporation, 3rd Floor Conference Center, 
3333 K Street, NW., Washington, DC 20007.

PUBLIC OBSERVATION: Unless otherwise noticed, all meetings of the LSC 
Board of Directors are open to public observation. Members of the 
public that are unable to attend but wish to listen to a public 
proceeding may do so by following the telephone call-in directions 
given below. You are asked to keep your telephone muted to eliminate 
background noises. From time to time the presiding Chair may solicit 
comments from the public.

Call-In Directions for Open Sessions:
     Call toll-free number: 1-(866) 451-4981;
     When prompted, enter the following numeric pass code: 
5907707348;
     When connected to the call, please ``MUTE'' your telephone 
immediately.

STATUS OF MEETING: Open.

Matters To Be Considered

OPEN SESSION

    1. Approval of agenda
    2. Report of the Search Committee regarding selection of a 
candidate for the position of LSC President
    3. Consider and act on the recommendation of the Search Committee
    4. Consider and act on other business
    5. Consider and act on adjournment of meeting

CONTACT PERSON FOR INFORMATION: Katherine Ward, Executive Assistant to 
the Vice President & General Counsel, at (202) 295-1500. Questions may 
be sent by electronic mail to [email protected].

SPECIAL NEEDS: Upon request, meeting notices will be made available in 
alternate formats to accommodate visual and hearing impairments. 
Individuals who have a disability and need an accommodation to attend 
the meeting may notify Katherine Ward, at (202) 295-1500 or [email protected].

[[Page 82412]]

    Dated: December 27, 2010.
Patricia D. Batie,
Corporate Secretary.
[FR Doc. 2010-32980 Filed 12-28-10; 11:15 am]
BILLING CODE 7050-01-P
```
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                             928
<SECURITIES>                                     3,338
<RECEIVABLES>                                    1,655
<ALLOWANCES>                                         0
<INVENTORY>                                        770
<CURRENT-ASSETS>                                 9,864
<PP&E>                                          13,409
<DEPRECIATION>                                 (7,348)
<TOTAL-ASSETS>                                  29,565
<CURRENT-LIABILITIES>                           10,723
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            81
<OTHER-SE>                                      33,647
<TOTAL-LIABILITY-AND-EQUITY>                    29,565
<SALES>                                            791
<TOTAL-REVENUES>                                 7,644
<CGS>                                                0
<TOTAL-COSTS>                                   19,640
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  66
<INCOME-PRETAX>                               (11,719)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (11,719)
<EPS-PRIMARY>                                   (1.44)
<EPS-DILUTED>                                        0
        

</TABLE>
# Search Census Archive

Home

## 2007

**Issuing Agency:** NASS

**Date of Publication:** 2007

**Rights:** Public Domain 1.0

**Description:**
This year’s census has additional online resources that supplement the publications in this archive.

These links provide tools offering an overview and/or comparisons of U.S., State, and County data, and key Census subject areas.
-  Quick Stats 2.0
-  Desktop Data Query Tool 1.02

The following special interest reports were cancelled this year:
- Census of Aquaculture
- Land Economics and Ownership

**

### 						Census Full Report					

#### U.S. Summary and State Data

#### State and County Data

#### Outlying Areas

**

### 						Online Resources					

**

### 						Special Studies					

**

### 						Rankings and Profiles					

#### Regional Studies

#### Rankings

**

### 						Custom Census Products					

**

### 						Related Information					

### Other Years

#### 				2012			

#### 				2007			

#### 				2002			

#### 				1997			

#### 				1992			

#### 				1987			

#### 				1982			

#### 				1978			

#### 				1974			

#### 				1969			

#### 				1964			

#### 				1959			

#### 				1954			

#### 				1950			

#### 				1945			

#### 				1940			

#### 				1935			

#### 				1930			

#### 				1925			

#### 				1920			

#### 				1910			

#### 				1900			

#### 				1890			

#### 				1880			

#### 				1870			

#### 				1860			

#### 				1850			

#### 				1840			

- Home
- Login

- Home
- Login

repliche rolex orologigenți falsereplique breitling

**Partners:**

National Agricultural Statistics Service (NASS)

Albert R. Mann Library, Cornell UniversityUnited States Department of Agriculture

**Developed & supported by:**

**Albert R. Mann Library****Cornell University****Ithaca, NY 14853-4301**Phone: **(607) 255-5406**Email: **usda-help@cornell.edu**
April 2 , 2015



### JUDGMENT


## The Fourteenth Court of Appeals

LISA ANN BARFIELD , Appellant

NO. 14

- 13

- 00518

- CR V.

THE STATE OF TEXAS , Appellee

_________ _______________________ This cause was heard on the transcripts of the record of the court below, and having inspected the record, the Court holds there was no error in the judgment requiring reversal, but there was error in the ju dgment as entered, which is cap able of reformation by this Court. Therefore, the judgment is REFORMED to delete the notation of “BAC .08” in the offense for which appellant was convicted

. The Court orders the judgment AFFIRMED as REFORMED

. We further order appellant pay all co sts expended in the appeal.

We order this decision certified below for observance.
§ 556.517 Poloxalene. ( a ) [Reserved]
( b ) *Tolerances.* The tolerance for poloxalene is: ( 1 ) *Cattle.* Edible tissues (excluding milk): Not required.
( 2 ) [Reserved]
( c ) *Related conditions of use.* See §§ 520.1840 and 558.464 of this chapter.
[84 FR 32993, July 11, 2019, as amended at 86 FR 14821, Mar. 19, 2021]
§ 522.1085 Guaifenesin powder for injection. ( a ) *Specifications.* The product is a sterile powder containing guaifenesin. A solution is prepared by dissolving the drug in sterile water for injection to make a solution containing 50 milligrams of guaifenesin per milliliter of solution.
( b ) *Sponsors.* See Nos. 037990 and 054771 in § 510.600(c) of this chapter.
( c ) *Conditions of use in horses* — ( 1 ) *Amount.* Administer 1 milliliter of prepared solution per pound of body weight by rapid intravenous infusion.
( 2 ) *Indications for use.* For use as a muscle relaxant.
( 3 ) *Limitations.* Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[79 FR 16189, Mar. 25, 2014]
#### § 19.6 Code of ethics for government service.

The following code of ethics, adopted by Congress on July 11, 1958, shall apply to all Food and Drug Administration employees:

# Code of Ethics for Government Service

Any person in Government service should:

1. Put loyalty to the highest moral principles and to country above loyalty to persons, party, or Government department.

2. Uphold the Constitution, laws, and legal regulations of the United States and of all governments therein and never be a party to their evasion.

3. Give a full day's labor for a full day's pay; giving to the performance of his duties his earnest effort and best thought.

4. Seek to find and employ more efficient and economical ways of getting tasks accomplished.

5. Never discriminate unfairly by the dispensing of special favors or privileges to anyone, whether for remuneration or not; and never accept, for himself or his family, favors or benefits under circumstances which might be construed by reasonable persons as influencing the performance of his governmental duties.

6. Make no private promises of any kind binding upon the duties of office, since a Government employee has no private word which can be binding on public duty.

7. Engage in no business with the Government, either directly or indirectly, which is inconsistent with the conscientious performance of his governmental duties.

8. Never use any information coming to him confidentially in the performance of governmental duties as a means for making private profit.

9. Expose corruption wherever discovered.

10. Uphold these principles, ever conscious that public office is a public trust.
#### Norman S. Chapin *v.*John J. Tynan, Commissioner of Motor Vehicles, et al.

King, C. J., Alcorn, House, Thim and Ryan, Js.

Argued December 9

decided December 9, 1969

*H. David Leventhal,*for the appellant (plaintiff).

*Stephen J. O’Neill,*assistant attorney general, with whom, on the brief, was *Robert K. Killian,*attorney general, for the appellee (named defendant).

*George F. Lowman,*with whom were *John F. Spindler*and, on the brief, *James M. Barton,*for the appellee (defendant R. L. Polk and Company).

Per Curiam.

There is no error.
§ 349.65 Labeling of ophthalmic emollient drug products. ( a ) *Statement of identity.* The labeling of the product contains the established name of the drug(s), if any, and identifies the product as a “lubricant” or “emollient (lubricant)” (select one of the following: “eye” or “ophthalmic”) “(insert dosage form, e.g., ointment).”
( b ) *Indications.* The labeling of the product states, under the heading “Indications,” one or more of the following phrases: ( 1 ) “For the temporary relief of burning and irritation due to dryness of the eye.”
( 2 ) “For the temporary relief of discomfort due to minor irritations of the eye or to exposure to wind or sun.”
( 3 ) “For use as a protectant against further irritation or to relieve dryness of the eye.”
( 4 ) “For use as a lubricant to prevent further irritation or to relieve dryness of the eye.”
( c ) *Warnings.* In addition to the warnings in § 349.50, the labeling of the product contains the following warnings under the heading “Warnings” for products containing any ingredient identified in § 349.14: “If you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours, discontinue use and consult a doctor.”
( d ) *Directions.* The labeling of the product contains the following information under the heading “Directions”: Pull down the lower lid of the affected eye and apply a small amount (one-fourth inch) of ointment to the inside of the eyelid.
Josh Kendrick FedEx Express

- AOD Telephone 901.224.0802

Managing Director 3131 Democrat Rd. Mobile 901.579.9018

Flight Technical & Reg. Compliance Building C, Suite 171 Fax 901.224.5516

Memphis, TN 38118

December 4, 2015

Mr. Hal Medling

Supervisory Principal Operations Inspector

FAA/ FedEx Certificate Management Office

2847 Business Park Drive, Building J

Memphis, TN 38118

Subject: Letter of Intent for Issuance of Exemption No. 12555 from 91.227 of Title 14, Code of

Federal Regulations

Dear Inspector Medling :

FedEx Express submits this Letter of Intent for Issuance of Exemption No. 12555 from 14 CFR 91.227

IAW Regulato ry Docket No. FAA

- 2015

- 0971. This exemption pertains to the 2020 mandate for ADS

- B

O UT positioning source accuracy requirements in the National Airspace System.

Attached with this Letter of Intent is information pertaining to completing Exemption No. 12555.

The contents are organized as follows:

Chapter 1

- Letter of Intent, Exemption No. 12555

Chapter 2

- Regulatory Docket No. FAA

- 2015

- 0971

Chapter 3

- ADS

- B Exemption Petition Diagram

Chapter 4

- Upgrade Plan Template.xlsx

We understand the Upgrade Plan process will require close coordination between your staff and mine.

We stand ready to resolve any issues or concerns that you find need additional attention or clarification.

My point of contact for this project is Larry Hills, System Technical Pilot, (901) 224

- 5170.

Sincerely,

Josh Kendrick

M anaging Director

Flight Technical & Regulatory Compliance

FedEx Express

– Air Operations Division

JBK/shd/ lch
;_ j**---~** 

### ....... l+l_**~JZ»s~e** /t1/IJ(7W**c..X:JaT-6?~..r::r_d..L&~r2** /s

## -----++ii..J-19~·**~G~~E** ;.s-,L.&/)/_£1

## ~.;;17_£2gLZ2Ed5s:i**/h'E~--**

. t lj

### (J&y-4~V/f/L**T2;~** ·-/IRE. _kJE

### ~d=-L!LLJ.LA!T**~_/!/·.** 

### &--<J4..r-.J<;K7**~** t ' 

### ----'--'--+)+---!**l~fl&....lal.cs--** E&Je 

### TP'J5**;r7e.J9'./I/~~ir.T~T-7ClfiL_&E** _

. 1

### ...------~-it+-l--.:Jt:f~ucs-:, N

### ~ 

## .pg a.c:JL.Ej N&Lb.e-sC> ·

### ~e!>_Ll~~ . / 1 -? / d d'J 

## Je.



# . !I f':h;i;).::) :1

### ;Cf~ s-- ;'l'z,{lf/7&/J/J; :4'

### ~A'?~AIN: j'::::rc::J !f'_ J" Qd._C/.c;d_

;i

. . /.

.

### lj·£v#e.-T/~flS.**~»WiJ -~N)I·?-~.!9./'eL**  '.1

### TE/71~**~**



### _____

### ;+;j....L·N~JC. ......

### -.L-E~_LZ -?/e

### ~/Vs .,/daLer

### &77~4~.,.'------~--~--**~-** i

. lj 

# Y#c as-L...J-:u)LJ 2CJftn

### MV~-&Es-~---.**_·__..c2~E-·** ___ _ ; l

. 

# ; I -Ca u /.1-/-;P'&s--T

### »~&l'X N

### ~-,4 ,)(1_£_ ·

### Jr:2~12dC L'ITCJ A-/ 

# il

#L8s-kl9 ·/4/£_-.LnY'ES: 

### Fml!f Z7:l;EJ/€ 

### ·.0.1<?-jL-·**l!~ ~12#~** **E_L!L?~..:;_·r-rz~l;__:C?=-..J~V~£=** 

### ..... .£.::,4<::..!;.**~=· .·L...;~~····y:-L.,**  _________ •

### ~l**f0££j.;;t~1?E ~/.~JowJ**  7/7'-E -);.../(!J/CJ.2

### ~;Es-s£,A-/7ih**Jll~s ~c$:e£i14T** **~-P~i£/2.L!I** J/1/G; · Ed?£ 

## T/7' £s-e

i {

## ~~ J s-;?_

## .19~.0**(~&** /'--"Z /'1 VA,!/ /EG_

## -~ ·c2·E 

### /./Z4.J4s/-c,4

...

.'{.,

! 1 : ' :: •**~-.** ;

.. "·!

.. {
38486.

#### HOLCOMB *et al.*v. BIVENS *et al.*

Jordan, Judge.

This was a suit by two- named attorneys for a declaratory judgment as to the priority of the plaintiffs’ attorney’s lien over the defendant Bivens’ security deed to certain described real property and for a permanent injunction, enjoining the defendants from exercising the power of sale contained in their security deed, the same being in default. The trial court sustained the defendant’s oral motion to dismiss the petition, and dismissed the same. The exception is to that judgment, it being recited in the bill of exceptions that “the injunctive relief sought has now become moot, and the sole question now left is the determination by the court of the priority of the plaintiffs in error attorney’s lien.” *Held:*

While under Ga. L. 1959, p. 236, amending the Declaratory Judgments Act (Ga. L. 1945, p. 137; *Code Ann.*§ 110-1101 et seq.), by adding thereto Section 1 (c), one is not precluded from obtaining relief by declaratory judgment merely because the complaining party has other adequate legal or equitable remedy or remedies, yet, where, as in the instant case, the petition shows that the rights of the parties have already accrued and no facts or circumstances are alleged which show the necessity for a determination of any dispute to guide and *87protect the petitioners from uncertainty and insecurity with respect to the propriety of some future act or conduct which is properly incident to their alleged right, which future action without direction would jeopardize their interests, the petition fails to state a cause of action for a declaratory judgment. *Pinkard v. Mendel,*216 Ga. 487 (117 S. E. 2d 336); *State Highway Dept. v. Ga. S. & F. Ry. Co.,*216 Ga. 547 (117 S. E. 2d 897); *Sumner v. Davis,*211 Ga. 702 (88 S. E. 2d 392); *State of Georgia v. Hospital Authority of Gilmer County,*213 Ga. 894, 898 (102 S. E. 2d 543); *McCallum v. Quarles,*214 Ga. 192 (104 S. E. 2d 105). Accordingly, the petition failing to state a cause of action for a declaratory judgment and the plaintiffs not being entitled under the pleadings to any other relief, the trial court did not err in dismissing the plaintiffs’ petition on oral motion of the defendants.

Decided January 11, 1961

Rehearing denied January 30, 1961.

*Milton Grubbs, Jr., Holcomb & McDuff, Frank D. Holcomb, Robert E. McDuff,*for plaintiffs in error.

*Allen, Duncan & Ford, Vernon W. Duncan,*contra.

*Judgment affirmed.*

*Townsend, P. J., Carlisle and Frankum, JJ., concur.*
<TABLE> <S> <C>

<PAGE>
<ARTICLE>               5

<S>                             <C>
<PERIOD-TYPE>                                    9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                       6,714,752
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                               7,218,502
<CURRENT-LIABILITIES>                          407,833
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                   6,810,669
<TOTAL-LIABILITY-AND-EQUITY>                 7,218,502
<SALES>                                              0
<TOTAL-REVENUES>                             1,394,006
<CGS>                                                0
<TOTAL-COSTS>                                1,517,424
<OTHER-EXPENSES>                             (568,195)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              84,280
<INCOME-PRETAX>                              4,038,010
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          4,038,010
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 4,038,010
<EPS-BASIC>                                      47.47
<EPS-DILUTED>                                    47.47


</TABLE>
§ 56.108 IRB functions and operations. In order to fulfill the requirements of these regulations, each IRB shall: ( a ) Follow written procedures: ( 1 ) For conducting its initial and continuing review of research and for reporting its findings and actions to the investigator and the institution;
( 2 ) for determining which projects require review more often than annually and which projects need verification from sources other than the investigator that no material changes have occurred since previous IRB review;
( 3 ) for ensuring prompt reporting to the IRB of changes in research activity; and
( 4 ) for ensuring that changes in approved research, during the period for which IRB approval has already been given, may not be initiated without IRB review and approval except where necessary to eliminate apparent immediate hazards to the human subjects.
( b ) Follow written procedures for ensuring prompt reporting to the IRB, appropriate institutional officials, and the Food and Drug Administration of: ( 1 ) Any unanticipated problems involving risks to human subjects or others;
( 2 ) any instance of serious or continuing noncompliance with these regulations or the requirements or determinations of the IRB; or
( 3 ) any suspension or termination of IRB approval.
( c ) Except when an expedited review procedure is used (see § 56.110), review proposed research at convened meetings at which a majority of the members of the IRB are present, including at least one member whose primary concerns are in nonscientific areas. In order for the research to be approved, it shall receive the approval of a majority of those members present at the meeting.
[46 FR 8975, Jan. 27, 1981, as amended at 56 FR 28028, June 18, 1991; 67 FR 9585, Mar. 4, 2002]